(Q73411374)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

main subject

phase II clinical trial

1 reference

1 reference

1 reference

1 reference

V Ratanatharathorn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

V Lorvidhaya

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S Maoleekoonpairoj

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P Phromratanapongse

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S Sirilerttrakul

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P Kraipiboon

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A Cheirsilpa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S Tangkaratt

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

V Srimuninnimit

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P Pattaranutaporn

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

257-265

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165405%20AND%20SRC:MED&resulttype=core&format=json

Review of the curative role of radiotherapy in the treatment of non-small cell lung cancer

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Recent Outcomes for Patients with Carcinoma of the Lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Non-small-cell lung cancer: should unresectable stage III patients routinely receive high-dose radiation therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Promising new agents in the treatment of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Impact of tumor control on survival in carcinoma of the lung treated with irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: a retrospective multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900171-9

7 January 2021

10.1016/S0169-5002(00)00171-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference